Company CVR Medical Corp. Deutsche Boerse AG
Equities
B3BN
CA1266321084
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.007 EUR | -26.32% | -.--% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Rhodes
CEO | Chief Executive Officer | - | 21-01-19 |
Paul S. Blunden
PSD | President | - | 16-10-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul S. Blunden
PSD | President | - | 16-10-19 |
Phillip Bendick
BRD | Director/Board Member | - | 20-02-12 |
Joseph Lynch
BRD | Director/Board Member | - | 20-02-16 |
Trish Howell
BRD | Director/Board Member | - | 20-03-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 107,233,206 | 93,517,112 ( 87.21 %) | 0 | 87.21 % |
Company contact information
CVR Medical Corp.
221 West Esplanade Suite 409
V7M 3J3, North Vancouver
+757-909-0491
http://www.cvrmed.comSector
1st Jan change | Capi. | |
---|---|---|
-18.88% | 11.03B | |
+53.75% | 3.5B | |
-32.50% | 2.23B | |
-14.31% | 2.16B | |
-26.83% | 1.54B | |
+28.55% | 1.12B | |
-3.28% | 737M | |
-23.50% | 477M | |
-43.27% | 411M |
- Stock Market
- Equities
- CVM.H Stock
- B3BN Stock
- Company CVR Medical Corp.